Athens, Georgia – – August 19, 2008 ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has entered into an exclusive worldwide technology licensing agreement with the University of Georgia Research Foundation that will enable the company to commercialize human mesenchymal cells developed at the University of Georgia. […]
Cambridge Isotope Laboratories Cambridge Isotope Laboratories (CIL), the world’s leader in the manufacturing of stable isotope labeled research chemicals has entered into a distributor agreement with CellFree Sciences Co., Ltd. (CFS) for the distribution of CFS’s WEPRO Expression Kits and reagents for cell-free protein production for NMR and Mass Spectrometry applications in North America and […]
IJSSELSTEIN, Netherlands & HYDERABAD, India–Isogen Biosolutions B.V. has rebranded itself as Ocimum Biosolutions B.V. The aim of the rebranding exercise is to tap the emerging opportunities and need for globalized solutions in Genomics. This represents a significant milestone in company’s history as the company hones its position as the premier integrated global genomics solutions provider. […]
KOBE, Japan, Aug. 8 — Carna Biosciences, Inc. (“Carna”) is pleased to announce the signing of a collaborative agreement with Caliper Life Sciences, Inc. USA (“Caliper”) on August 6 (US Eastern Daylight Time). Carna will supply a set of discrete protein kinases aiding the expansion of Caliper’s kinase profiling and assay development services, and ProfilerPro […]
MADISON, Wis.–Promega Corporation announces a new plasmid isolation system that simplifies and speeds the preparation of plasmid DNA. The Promega PureYield™ Plasmid Miniprep System allows researchers to purify plasmid DNA in less than 10 minutes from 600µl to 3 ml of culture with fewer steps. The smooth work flow is further enhanced with the lysis/neutralization […]
Company expands beyond core business of discovery and safety services to BOSTON and CLEVELAND, Aug. 6 — ChanTest, the world-leading provider of validated ion channel-expressing cell lines and services for drug-discovery and development applications, will make a selection of its fully validated cell lines available to researchers through a new Web site: https://www.chantestchannels.com. ChanTest Founder […]
CARLSBAD, Calif. & BALTIMORE–Invitrogen Corporation (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, and Lentigen Corporation, a privately-held biotechnology company specializing in the development and manufacture of lentiviral gene delivery technologies, announced today a partnership to develop and supply gene over-expression products and services. Invitrogen will exclusively commercialize […]
Rutgers University Genetics Researcher Reports Superior Extraction Results FULLERTON, Calif. (August 4, 2008) – Beckman Coulter, Inc. introduces the Agencourt® DNAdvance™ System, a new extraction kit for DNA isolation and purification from mammalian tissue samples. The new system delivers a combination of recovery, yield and purity not available with any other kit on the market […]
Calif. (July 31, 2008) – Beckman Coulter, Inc. introduces an enhanced Chiral Methods Development Kit for CE (capillary electrophoresis) analysis on the company’s P/ACE™ MDQ System. The new kit features highly sulfated cyclodextrins (HSCDs), a family of three chiral reagents that deliver excellent performance in the separation of most neutral, basic and weakly acidic compounds […]
CARLSBAD, Calif. & NOVATO, Calif.–Invitrogen Corporation (NASDAQ:IVGN – News), a provider of essential life science technologies for research, production and diagnostics, has licensed an engineered stem cell line from the Buck Institute for Age Research. The stem cell line is used in the study of neural cells in neurodegenerative disease. The financial terms were not […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
